603235 天新药业
2025/09 - 九个月2024/122023/122022/122021/12

盈利能力分析
净资产收益率 ROE (%)9.79314.71911.47920.85348.563
总资产报酬率 ROA (%)7.97912.1809.74116.30225.383
投入资产回报率 ROIC (%)9.24514.21511.24519.44338.667

边际利润分析
销售毛利率 (%)45.34242.01138.27237.22543.251
营业利润率 (%)33.92335.06129.87431.48634.759
息税前利润/营业总收入 (%)32.11029.96124.58827.56036.061
净利润/营业总收入 (%)28.22329.48625.28526.99229.491

收益指标分析
经营活动净收益/利润总额(%)95.20695.15192.31391.24695.355
价值变动净收益/利润总额(%)1.2000.9960.3671.511-0.757
营业外收支净额/利润总额(%)-0.293-0.3350.5220.009-0.390

偿债能力分析
流动比率 (X)5.4765.2876.76610.1752.333
速动比率 (X)4.3114.1315.7288.6631.734
资产负债率 (%)19.36317.62216.84113.29035.348
带息债务/全部投入资本 (%)1.005-3.915-5.832-6.8322.632
股东权益/带息债务 (%)9,211.373-2,462.095-1,659.567-1,452.4163,139.465
股东权益/负债合计 (%)416.454467.476493.804652.428182.901
利息保障倍数 (X)-18.742-6.012-4.518-7.01325.091

营运能力分析
应收账款周转天数 (天)43.50142.09746.59346.22738.788
存货周转天数 (天)172.635150.130147.134109.00492.540